SGLT2i are often compared in mode of action to calorie restriction mimetics. Here is a terrific paper that overviews the subject in the context of other CR mimetics, and pathways, such as utilized by rapamycin:
SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases
https://academic.oup.com/endo/article/162/8/bqab079/6226811?login=false
Quote:
“There has been longstanding interest in anti-aging pathway modulators that replace the benefits of CR. We present an overview of metformin, rapamycin, resveratrol and NAD+ boosters as alternative anti-aging compounds”.